INDIA MARKET LENS
◆ Mixed

Lupin launches fixed-dose triple-combination inhaler for COPD in India

6 Oct 2026 · BS Companies

Formoflo-G MDI combines three established therapies in a twice-daily inhaler after DCGI approval, targeting India's large COPD patient…

Continue in the original report ↗